An interventional study of Whole cow's milk and Non-fat or low-fat cow's milk in Pediatric Obesity, Child Nutrition and Early Child Development and Child Development, sponsored by University of California, Davis. Completed at 1 site in United States. Open to participants aged 11 Months to 24 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by University of California, Davis · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 558 studies in Pediatric Obesity with a site in United States — 73 open to participants now, 109 under way, 3 of them phase 3. Pediatric Obesity · United States.
Among the 558 studies in Pediatric Obesity with a site in United States, this one is the 377th largest by enrollment of the 475 interventional ones that give a count, is one of 39 that started in 2021, is one of 423 with no phase, and was the 558th registered.
1,131 studies on the registry are indexed under Pediatric Obesity; 183 are open to participants now.
Browse Pediatric Obesity studies →73 of the 558 studies in Pediatric Obesity with a site in United States are open now. Recruiting first, the newest first:
Stanford University · Sites in United States
Ages 10–15
Children's Hospital Los Angeles · Sites in United States
Ages 12–18
Virginia Commonwealth University · Sites in United States
Ages 12–15 · Healthy volunteers
University of Michigan · Sites in United States
Ages 4 mo+ · Healthy volunteers
Russell McCulloh, MD · Sites in United States
Ages 12–17
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 120 Pediatric Obesity studies recruiting now, 17 (14%) set no upper age limit and 101 (84%) stop at 75 or younger; 111 take children under 18; 67 take healthy volunteers.
This study: 11 Months to 24 Months · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
558 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 13 · Phase 2 27 · Phase 3 10 · Phase 4 11
First in 1998; this study’s year is marked. 39 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 33 is below the median of 100 across 872 interventional studies indexed under Pediatric Obesity.
Median enrollment 95 across the 475 interventional studies, 120 across the 81 observational. Of the 419 that completed or were terminated, 116 (28%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 558 have an industry lead sponsor. The 10 most frequent:
University of California, Davis is the lead sponsor of 811 studies on the registry; 142 are open to participants now.
Of its 67 completed or terminated interventional studies of FDA-regulated products, 43 (64%) have results posted.
University of California, Davis has 4 studies filed under Pediatric Obesity — fewer than ten, so there is no comparison to draw.
39 of the studies in Pediatric Obesity with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04974554Medical University of South CarolinaFIT Families Multicomponent Obesity Intervention for African American Adolescents | 2026-11-30 |
| NCT06810557Temple UniversityBrief Behavioral Sleep Intervention for Obesity Prevention in Primary Care | 2026-11-30 |
| NCT04971044Vanderbilt University Medical CenterCompetency Based Approaches for Community Health 2 | 2026-12 |
| NCT05067621Yale UniversitySemaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease | 2026-12 |
| NCT04128995Children's Hospital Medical Center, CincinnatiSurgical or Medical Treatment | 2026-12 |
Add all 39 to your calendar (.ics) → With an account.
Among the 558 studies in Pediatric Obesity with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
In the United States, children who are not breastfed are advised to drink whole cow's milk from age 1 and switch to low-fat (1%) or non-fat milk at age 2. There is little trial evidence behind this switch, and some observational studies link lower-fat milk to higher body weight in children. This pilot study tested whether a larger, longer randomized trial of milk fat type in young children would be feasible and acceptable to families. Parents of young children in the San Francisco Bay Area were randomly assigned to give their child either whole milk or non-fat (or low-fat 1%) milk, delivered free to their home for 3 months. At the start and after 3 months, the study team measured the child's growth, development, diet, blood lipids, vitamin D level, and gut bacteria. Parents also reported any difficulties with taking part. The results will be used to design a fully powered, 1-year randomized controlled trial.
This was a two-arm, parallel-group, randomized pilot trial testing the feasibility and acceptability of the methods planned for a larger randomized controlled trial (RCT) of milk fat type in young children. The pilot had two objectives: (1) determine whether assigning milk type (whole vs. non-fat) and carrying out multiple study protocols and measures were feasible for families with young children; and (2) inform approaches for maximizing recruitment and retention in a 1-year RCT.
English-speaking parents of children aged 11-12 months who were not yet drinking cow's milk were recruited through social media, parent groups, and flyers in the San Francisco Bay Area. The target sample was 30 children. Enrolled children were randomized in matched pairs to whole or non-fat milk, using a random number generator run by the study data analyst. Pairs were matched on current breastfeeding status and parental obesity (BMI ≥30 kg/m², self-reported). Families received 2 gallons of cow's milk every 2 weeks for 3 months through a grocery delivery service, plus a cooler bag, a sippy cup, and a reminder magnet. The parent most responsible for feeding received telephone counseling from a Registered Dietitian on introducing the assigned milk. A second session was later made optional.
Measures at baseline and 3 months were: recumbent length, weight, weight-for-length z-score (WHO), waist and head circumference; three 24-hour dietary recalls (ASA24) at each time point; child development (DAYC-2: cognitive, communication, physical domains); non-fasting blood lipids (total, HDL, and non-HDL cholesterol) and 25-hydroxyvitamin D; and stool samples for gut microbiome diversity. Skin pigmentation was also recorded. Parents completed a baseline sociodemographic survey and an endpoint survey on study acceptability and difficulties.
Protocol modifications during the pilot: recruitment was slow, and parents worried about giving non-fat milk at age 1. In response, the eligible age range was expanded to 11-24 months, and families assigned to the reduced-fat arm could receive low-fat (1%) milk instead of non-fat. Because of a COVID-19 surge, some endpoint anthropometric measures were taken by parents with virtual guidance, and the DAYC-2 was moved to Zoom.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Children received whole (about 3.5% fat) cow's milk, 2 gallons delivered every 2 weeks for 3 months, plus Registered Dietitian counseling on introducing the assigned milk.
Other: Whole cow's milk · Behavioral: Registered Dietitian counseling
Children received non-fat cow's milk, or low-fat (1%) milk once that option was added mid-study, on the same delivery schedule for 3 months, plus Registered Dietitian counseling.
Other: Non-fat or low-fat cow's milk · Behavioral: Registered Dietitian counseling
Non-organic whole cow's milk delivered free to the home through a grocery delivery service, 2 gallons every 2 weeks for 3 months. A cooler bag, ice pack, child cup, and reminder magnet were provided.
Non-organic non-fat cow's milk, or low-fat (1%) milk after the protocol change, delivered free to the home on the same schedule for 3 months, with the same supplies. Other names: skim milk; 1% milk
Telephone counseling for the parent most responsible for feeding, on introducing the assigned milk, moving from breastmilk or formula, age-appropriate amounts, and cup use. One session was required and a second was optional.
Recruitment: number of participants screened and enrolled
Number of parents screened for eligibility and number enrolled during the recruitment period, against a target of 30 children.
Time frame: 6-months
Retention: percentage of enrolled participants completing the study
Percentage of enrolled children who completed both baseline and 3-month endpoint assessments.
Time frame: Baseline to 3 months
Completion rate for each study measure
Percentage of participants completing each measure (parent survey, anthropometry, DAYC-2, three 24-hour dietary recalls, stool sample, blood draw) at each time point.
Time frame: Baseline and 3 months
Acceptability: percentage of parents reporting difficulty with the intervention
Percentage of parents reporting one or more difficulties with the milk intervention (e.g., getting the child to drink the recommended amount, bottle weaning, milk storage, deliveries), on the endpoint survey.
Time frame: 3 months
Acceptability: percentage of parents reporting difficulty with data collection
Percentage of parents reporting one or more difficulties with data collection procedures (e.g., blood draws, scheduling, dietary recalls, dietitian consults), on the endpoint survey.
Time frame: 3 months
Weight-for-length z-score
Calculated from measured recumbent length and weight using WHO Child Growth Standards.
Time frame: Baseline and 3 months
Recumbent length
Measured to the nearest 0.1 cm.
Time frame: Baseline and 3 months
Weight
Measured to the nearest 0.1 kg, minimal clothing.
Time frame: Baseline and 3 months
Waist circumference
Measured to the nearest 0.1 cm.
Time frame: Baseline and 3 months
Head circumference
Measured to the nearest 0.1 cm.
Time frame: Baseline and 3 months
Total daily energy intake
Mean kcal/day from three 24-hour dietary recalls (ASA24-2022).
Time frame: Baseline and 3 months
Percent of energy from fat, added sugars, protein, and carbohydrate
Mean from three 24-hour dietary recalls (ASA24-2022).
Time frame: Baseline and 3 months
Daily milk, total dairy, and vitamin D intake
Mean from three 24-hour dietary recalls (ASA24-2022).
Time frame: Baseline and 3 months
Child development scores
DAYC-2 standard scores for cognitive, communication (receptive and expressive), and physical (gross and fine motor) domains.
Time frame: Baseline and 3 months
Serum lipid concentrations
Total cholesterol, HDL cholesterol, and non-HDL cholesterol (mg/dL), non-fasting.
Time frame: Baseline and 3 months
Serum 25-hydroxyvitamin D
Biomarker of vitamin D status (ng/mL).
Time frame: Baseline and 3 months
Gut microbiome alpha diversity
Faith's whole-tree phylogenetic diversity from stool DNA sequencing.
Time frame: Baseline and 3 months
Plan to share: No — Individual participant data from this pilot will not be made publicly available.
No publications or documents are linked to this record.
Ran from Sep 2021 to primary completion in Jul 2022, 10 months.
Of 542 non-industry interventional studies with no phase under Pediatric Obesity, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 45. This study's 10 months is below that.
Counting every sponsor, half of 544 studies reached it within 25 months; a quarter within 11 and three quarters within 45.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, Davis →